Analyst Coverage

Verona Pharma is covered by the following analysts.

Analyst Institution

Thomas Shrader PhD, CFA

BTIG

Edward Nash

Canaccord

Raghuram Selvaraju, PhD

H.C. Wainwright

Andrew Tsai

Jefferies

Yasmeen Rahimi, PhD

Piper Sandler

Joon Lee, MD, PhD

Truist Securities

Edward Thomason, CFA

Van Lanschot Kempen

Tiago Fauth

Wells Fargo

Developing novel therapeutics for respiratory diseases

Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.